These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6695822)

  • 1. Effects of flecainide on ventricular function: clinical and experimental correlations.
    Josephson MA; Ikeda N; Singh BN
    Am J Cardiol; 1984 Feb; 53(5):95B-100B. PubMed ID: 6695822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease.
    Josephson MA; Kaul S; Hopkins J; Kvam D; Singh BN
    Am Heart J; 1985 Jan; 109(1):41-5. PubMed ID: 3966331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.
    Legrand V; Vandormael M; Collignon P; Kulbertus HE
    Am J Cardiol; 1983 Feb; 51(3):422-6. PubMed ID: 6823856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The haemodynamic effect of intravenous flecainide acetate in patients with coronary artery disease.
    Serruys PW; Vanhaleweyk G; Van Den Brand M; Verdouw P; Lubsen J; Hugenholtz PG
    Br J Clin Pharmacol; 1983 Jul; 16(1):51-9. PubMed ID: 6882622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of flecainide acetate in the management of patients at high risk of sudden cardiac death.
    Reid PR; Griffith LS; Platia EV; Ord SE
    Am J Cardiol; 1984 Feb; 53(5):108B-111B. PubMed ID: 6695814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic dose-response effects of flecainide in acute myocardial infarction with and without left ventricular decompensation.
    Jackson N; Verma SP; Frais MA; Silke B; Hafizullah M; Reynolds G; Taylor SH
    Clin Pharmacol Ther; 1985 Jun; 37(6):619-24. PubMed ID: 3891187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flecainide in the treatment of nonsustained ventricular tachycardia.
    Lal R; Chapman PD; Naccarelli GV; Schechtman KB; Rinkenberger RL; Troup PJ; Kim SS; Dougherty AH; Ruffy R
    Ann Intern Med; 1986 Oct; 105(4):493-8. PubMed ID: 3752754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic and antiarrhythmic effects of intravenous flecainide acetate in chronic congestive heart failure.
    Dunselman PH; Kingma JH; van Wijk LM; Dijk A; Wesseling H; Lie KI
    Drugs; 1985; 29 Suppl 4():58-64. PubMed ID: 4006780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flecainide: a new prototype antiarrhythmic agent.
    Nappi JM; Anderson JL
    Pharmacotherapy; 1985; 5(4):209-21. PubMed ID: 3898035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiological effects of flecainide on stimulus-inducible ventricular tachycardia].
    Breithardt G; Borggrefe M; Yeh HL; Seipel L
    Z Kardiol; 1982 Apr; 71(4):278-83. PubMed ID: 7090468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of intravenous flecainide in acute noncomplicated myocardial infarction.
    Cohen AA; Daru V; Covelli G; Gonzalez M; Villamayor R; Tronge JE
    Am Heart J; 1985 Dec; 110(6):1193-6. PubMed ID: 4072876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative haemodynamic effects of intravenous flecainide in patients with and without heart failure and with and without beta-blocker therapy.
    Legrand V; Materne P; Vandormael M; Collignon P; Kulbertus HE
    Eur Heart J; 1985 Aug; 6(8):664-71. PubMed ID: 4054136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous and oral flecainide on ventricular tachycardia.
    Ward DE; Cheesman M; Dancy M
    Int J Cardiol; 1986 Mar; 10(3):251-62. PubMed ID: 3957470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flecainide: long-term treatment using a reduced dosing schedule.
    Flowers D; O'Gallagher D; Torres V; Miura D; Somberg JC
    Am J Cardiol; 1985 Jan; 55(1):79-83. PubMed ID: 3966401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of intravenous pirmenol.
    Morris KG; Phillips HR
    Angiology; 1988 Mar; 39(3 Pt 2):321-6. PubMed ID: 3354931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.
    Muhiddin KA; Turner P; Hellestrand K; Camm AJ
    Postgrad Med J; 1985 Jun; 61(716):489-96. PubMed ID: 2409543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pilsicainide on systemic hemodynamics and cardiac function of anesthetized dogs.
    Sakanashi M; Noguchi K; Matsuzaki T; Ojiri Y; Nakasone J; Itomine T; Higuchi M; Shiroma N
    Cardioscience; 1993 Dec; 4(4):241-50. PubMed ID: 8298065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic and hemodynamic actions of flecainide acetate (R-818) in the ischemic porcine heart.
    Verdouw PD; Deckers JW; Conrad GJ
    J Cardiovasc Pharmacol; 1979; 1(4):473-86. PubMed ID: 94625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.